| 000 | 01736 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516202110.0 | ||
| 264 | 0 | _c20141215 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1098-1136 | ||
| 024 | 7 |
_a10.1002/glia.22645 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXu, Min | |
| 245 | 0 | 0 |
_aInhibition of cysteine cathepsin B and L activation in astrocytes contributes to neuroprotection against cerebral ischemia via blocking the tBid-mitochondrial apoptotic signaling pathway. _h[electronic resource] |
| 260 |
_bGlia _cJun 2014 |
||
| 300 |
_a855-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis Inducing Factor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAstrocytes _xdrug effects |
| 650 | 0 | 4 |
_aBH3 Interacting Domain Death Agonist Protein _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aBrain Ischemia _xmetabolism |
| 650 | 0 | 4 |
_aCathepsin B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCathepsin L _xantagonists & inhibitors |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCysteine _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aEpoxy Compounds _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aYang, Lei | |
| 700 | 1 | _aRong, Jia-Guo | |
| 700 | 1 | _aNi, Yong | |
| 700 | 1 | _aGu, Wei-Wei | |
| 700 | 1 | _aLuo, Yu | |
| 700 | 1 | _aIshidoh, Kazumi | |
| 700 | 1 | _aKatunuma, Nobuhiko | |
| 700 | 1 | _aLi, Zhong-Sheng | |
| 700 | 1 | _aZhang, Hui-Ling | |
| 773 | 0 |
_tGlia _gvol. 62 _gno. 6 _gp. 855-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/glia.22645 _zAvailable from publisher's website |
| 999 |
_c23628030 _d23628030 |
||